Lupin Acquires Huminsulin from Lilly to Enhance Diabetes …
Mumbai, December 30, 2024: Global pharma major Lupin Limited (Lupin) announced today the acquisition of Huminsulin® in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio.
Lupin up 2%, hits new high on buying Eli Lilly's diabetes drug Huminsulin
Dec 31, 2024 · Lupin has been marketing the Huminsulin range of products, comprising Insulin Human, through its existing Distribution and Promotion Agreements with Eli Lilly, India. The Huminsulin drug is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and children.
Lupin acquires Huminsulin from Lilly to enhance diabetes portfolio
Dec 31, 2024 · Business News; business; ... “The Huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and children ...
Shares of Lupin Ltd reach all-time high price on acquiring Huminsulin …
Dec 31, 2024 · Shares of Lupin Ltd surged 2.38 per cent to ₹2,364.65 on the BSE at 11.27 AM and it reached an all-time high of ₹2,372.55 during the session. Lupin Ltd., a global pharmaceutical company ...
Lupin acquires Huminsulin from Lilly to strengthen diabetes …
Dec 30, 2024 · Global pharmaceutical giant Lupin on Monday announced the acquisition of Huminsulin in India from Eli Lilly and Company. This move aims to significantly strengthen Lupin's existing diabetes portfolio.
Lupin acquires Huminsulin for Type 1 and Type 2 diabetes
Dec 30, 2024 · The Huminsulin range of products is indicated for the treatment of Type 1 and Type 2 diabetes mellitus to improve blood sugar control in both adults and children, the company said. Insulin treatment is the cornerstone of Type 1 diabetes management and often becomes necessary over time in Type 2 diabetes as the disease progresses, it added.
Lupin acquires 'Huminsulin' in India from Eli Lilly and Co
Dec 30, 2024 · Lupin Ltd has acquired the anti-diabetic medicine Huminsulin in India from Eli Lilly to expand its diabetes portfolio. This move aims to provide high-quality, affordable healthcare for diabetes patients. Huminsulin is used for treating Type 1 and Type 2 …
Lupin acquires Huminsulin in India from Eli Lilly - The Hindu
Dec 30, 2024 · Lupin Ltd has announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio for an unspecified amount.
Lupin acquires Huminsulin from Eli Lilly to strengthen diabetes
Dec 30, 2024 · Drugmaker Lupin Ltd has acquired Huminsulin in India from Eli Lilly and Company, for an undisclosed amount. The move will strengthen Lupin’s diabetes footprint in the country.
Lupin acquires Huminsulin from Eli Lilly to enhance
Dec 30, 2024 · Pharma major Lupin has acquired Huminsulin brand in India from Eli Lilly, in an effort to enhance its diabetes portfolio, the company said in an exchange filing on December 30. Lupin had been...
- Some results have been removed